维普期刊资源整合服务平台（V6.5）

29篇 您的检索式：作者名="Batin M"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Risk stratification for ST segment elevation myocardial infarction in the era of primary percutaneous coronary intervention显示文摘Acute coronary syndromes presenting with ST elevation are usually treated with emergency reperfusion/revascularisation therapy. In contrast current evidence and national guidelines recommend risk stratification for non ST segment elevation myocardial infarction(NSTEMI) with the decision on revascularisation dependent on perceived clinical risk. Risk stratification for STEMI has no recommendation. Statistical risk scoring techniques in NSTEMI have been demonstrated to improve outcomes however their uptake has been poor perhaps due to questions over their discrimination and concern for application to individuals who may not have been adequately represented in clinical trials. STEMI is perceived to carry sufficient risk to warrant emergency coronary intervention [by primary percutaneous coronary intervention(PPCI)] even if this results in a delay to reperfusion with immediate thrombolysis. Immediate thrombolysis may be as effective in patients presenting early, or at low risk, but physicians are poor at assessing clinical and procedural risks and currently are not required to consider this. Inadequate data on risk stratification in STEMI inhibits the option of immediate fibrinolysis, which may be cost-effective. Currently the mode of reperfusion for STEMI defaults to emergency angiography and percutaneous coronary intervention ignoring alternative strategies. This review article examines the current risk scores and evidence base for risk stratification for STEMI patients. The requirements for an ideal STEMI risk score are discussed.	Richard A Brogan Christopher J Malkin Philip D Batin Alexander D Simms James M McLenachan Christopher P Gale	2014	World Journal of Cardiology2014，6，8：	6
2	Relationship between differing volumes of bone marrow aspirates and their cellular composition显示文摘	Batinic D Marusic M Pavletic Z	1990	Bone Marrow Transplant1990，6，2：	1
3	Ventricular dilatation in the absence of ACE inhibitors:influence of haemodynamic and neuroho-rmonal variables following myocardial infarctiol显示文摘	WALSH J T BATIN P D HAWKINS M	1999	Heart1999，，81：	1
4	Ventricular dilatation in the absence of ACE inhibitors:influence of haemodynamic and neurohormonal variables following myocardial infarction显示文摘	Walsh JT Batin PD Hawkins M	1999	Heart1999，81，：	1
5	Vesicoureteral reflux and urodynamic dysfunction显示文摘	Batinic D Milo(s)evic D Topalovic-Grkovic M	2013	Urol Int2013，90，4：	1
6	The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure显示文摘	Batin P Wickens M McEntegart D		0，，11：	1
7	TC-99mDTPA renal scintigraphy using deconnolution analysis with six funcional images of the mean time to evaluate pyelonephritis显示文摘	Poropat M batinic D Basic M	1999	Clin Nucl Med1999，24，2：	1
8	Biological and clinical features of adult biphenotypic acute leukemia:a case series显示文摘	Mikulic M Batinic D Rnjak L	2007	Blood Rev2007，21，：	1
9	Biological features and outcome of biphenotypic acute leukemia:a case series显示文摘	Mikulic M Batinic D Sucic M	2008	Hematol Oncol Stem Cell Ther2008，1，4：	1
10	Ventricular dilatation in the absence of ACE inhibitors : influence of haemodynamic and neurohomonal variablen following myocardial infarction 显示文摘	Walsh JT Batin PD Hawkins M	1999	Heart1999，81，：	1
11	The importance of abnor- malities of liver function tests inpredicting mortality in chronic heart failure 显示文摘	Batin P Wickens M McEntegart D	1995	Eur Heart J1995，16，11：	1
12	Vesicoureteral reflux and urodynamic dysfunction显示文摘	Batinic D Milosevic D Topalovic-Grkovic M er al		0，，04：	1
13	Prospective study of heart rate variability and mortality in chronic heart failure:results of the United Kingdom heart failure evaluation and asessment of risk trial (UK-heart)显示文摘	Batin PD Andrews R Lindsay SJ Brooksby P Mullen M Baig W Flapan AD Cowley A Prescott RJ Neilson JM Fox KA	1998	Circulation1998，98，15：	1
14	Ventricular dilatation in the absence of ACE inhibitors: influence of haemodynamic and neurohormonal variables following myocardial infarction 显示文摘	Walsh J T Batin M	1999	Heart1999，81，：	1
15	Management and health status in the first year after out -of- hospital cardiac arrest 显示文摘	Batin PD Bannister J Ryder M	1997	J Roy Coll Phys (Lond)1997，31，：	1
16	Biological agents targeting interleukin-18显示文摘	Lukic IK Batinic D	2007	Drug News Perspect2007，20，8：	1
17	Ventricular dilatation in the absence of ACE inhibiotrs:influence of haemodynamic and neurohormonal variables following myocardial infarction显示文摘	Walsh JT Batin PD Hawkins M	1999	Heart1999，81，1：	1
18	Ventricular dilatation in the absence of ACE inhibitors:influence of haemodynamic and neurohormonal variables following myocardial infarction 显示文摘	Walsh J T Batin P D Hawkins M	1999	Heart1999，81，：	1
19	YKL-40 is elevated in patients with pe- ripheral arterial disease and diabetes or pre-diabetes 显示文摘	Batinic K H6baus C Grujicic M Steffan A J elic F Lo rant D	2012	Atherosclerosis2012，222，：	1
20	Ventricular dilatation in the absence of ACE inhibitors: influence of haemodynamic and neurohormonal variables following myocardial infarction显示文摘	Walsh JT Batin PD Hawkins M	1999	Heart1999，81，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示